Rituximab use in multiple sclerosis has been promising. Cytokine release
syndrome (CRS) is a common side effect of rituximab in patients with
lymphoma. We report a case of a 44-year-old man with a history of
relapsing-remitting multiple sclerosis, who presented with signs and
symptoms consistent with CRS after rituximab initiation.